Video

Dr. Rose on the Importance of Genetic Testing in Ovarian Cancer

Stephen L. Rose, MD, UW Health, discusses the importance of genetic testing in ovarian cancer.

Stephen L. Rose, MD, director, Gynecologic Oncology program, Department of Obstetrics and Gynecology, University of Wisconsin (UW) Carbone Cancer Center, UW Health, discusses the importance of genetic testing in ovarian cancer.

 The importance of genetic testing in this patient population can be accredited to the use of PARP inhibitors, as PARP inhibitors have demonstrated improved outcomes when used as frontline treatment for certain patients with ovarian cancer, Rose says. Moreover, patients can be started on PARP inhibitors quickly based on their somatic or germline BRCA mutational status and their homologous recombination proficiency or deficiency (HRD) status, which is beneficial, Rose expands. However, a barrier to widespread implementation of genetic testing has been the lack of timely genetic counseling in a timely manner, Rose adds. 

Trying to utilize virtual visits to increase efficiency and get patients through the system can be beneficial, Rose continues. Additionally, although somatic BRCA mutational testing, as well as HRD testing, can be beneficial, concurrent somatic and germline testing is recommended up front to ensure that all eligible patients receive PARP inhibitor maintenance therapy, Rose concludes.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Expert Perspectives on Applying Recent Evidence to Practice in the Management of Newly Diagnosed Multiple Myeloma
Video

Expert Perspectives on Applying Recent Evidence to Practice in the Management of Newly Diagnosed Multiple Myeloma

Jun 19th 2025 - Jul 25th 2025

online-activity
Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies
Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies

Jun 18th 2025 - Jun 19th 2026

online-activity
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity